Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

Authors

  • Anna E. C. A. B. Willemsen Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • Carla M. L. van Herpen Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • Pieter Wesseling Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • Peter Bult Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • Hanneke W. M. van Laarhoven Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

DOI:

https://doi.org/10.3109/0284186X.2010.491088

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-04-01

How to Cite

Willemsen, A. E. C. A. B., van Herpen, C. M. L., Wesseling, P., Bult, P., & van Laarhoven, H. W. M. (2011). Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma. Acta Oncologica, 50(3), 462–465. https://doi.org/10.3109/0284186X.2010.491088

Issue

Vol. 50 No. 3 (2011): Acta Oncologica

Section

Articles